Euractiv (Partner Content)
EU Perspectives
European Biotechnology Magazine
APM Market Access
EU PERSPECTIVES - Europe's top life sciences investors have welcomed the EU's new €5bn Scaleup Europe Fund. One of its own backers, Novo Holdings, has just put €500m into it. Yet the same investors told EU Perspectives the fund will barely touch their sector's real funding problem. Read more
EURACTIV - Hungarian universities remain barred from the EU's flagship Horizon research programme, it has no national dementia plan, and the diagnostic infrastructure the new drugs depend on barely exists. Read more
EU PERSPECTIVES - Tariff threats are working, the president declared, crediting them with forcing pharma companies and foreign governments to accept his most-favoured-nation pricing plan. Instead of driving prices sharply lower in the US, however, it could push them up for everyone else. Read more
EU PERSPECTIVES - A mother who survives childbirth. A child who reaches their fifth birthday. This is what Dr Hans Kluge says his campaign for the world's top health job comes down to. The doctor who once treated tuberculosis in Siberian prisons is now Belgium's WHO candidate, backed by Prime Minister Bart De Wever as "someone who...
